SEARCH BY

Issuer directory Issuer directory
KEYWORDS
COMPANIES / ISIN
TYPE OF INFORMATION
INDUSTRY

Start search  ADVANCED SEARCH

COMPARTMENTS / INDICES

France
America
Asia
Oceania
Africa
Europe

CAC 40 NEWS

FEEDS

My RSS My Google Microsoft Live My Yahoo

COMPANY SEARCH RESULT

Sanofi-Aventis: Click to view the issuer\'s details

Last update : 23/02/2016  >View issuer details

2018.01.22 | 18:00 | Share Buybacks / Share redemption disclosures

English version HTML (w) Mail

puce Sanofi: Disclosure of trading in own shares - HTML (w)

2018.01.22 | 18:00 | Share Buybacks / Share redemption disclosures

French version HTML (w) Mail

puce Sanofi : Déclaration des transactions sur actions propres - HTML (w)

2018.01.22 | 07:00 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Sanofi to Acquire Bioverativ for $11.6 Billion - HTML (w)

2018.01.22 | 07:00 | Permanent Information Releases / General Company News

French version HTML (w) Mail

puce Sanofi va acquérir Bioverativ pour 11,6 milliards de dollars - HTML (w)

2018.01.15 | 17:45 | Share Buybacks / Share redemption disclosures

English version HTML (w) Mail

puce Sanofi : Disclosure of trading in own shares - HTML (w)

2018.01.15 | 17:45 | Share Buybacks / Share redemption disclosures

French version HTML (w) Mail

puce Sanofi : Déclaration des transactions sur actions propres - HTML (w)

2018.01.08 | 17:40 | Share Buybacks / Share redemption disclosures

English version HTML (w) Mail

puce Sanofi : Disclosure of trading in own shares - HTML (w)

2018.01.08 | 17:40 | Share Buybacks / Share redemption disclosures

French version HTML (w) Mail

puce Sanofi : Déclaration des transactions sur actions propres - HTML (w)

2018.01.08 | 13:00 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Sanofi and Regeneron to accelerate and expand investment for cemiplimab and dupilumab development programs - HTML (w)

2018.01.07 | 21:00 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Sanofi and Alnylam enter into strategic restructuring of RNAi therapeutics rare disease alliance - HTML (w)

Pages : 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 - 10 / Doc nb : 2420